FDA 483 - Sun Pharmaceutical Industries Ltd. - May 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sun Pharmaceutical Industries Ltd. in Halol, Gujarat, India, received a Form 483 with 10 observations primarily concerning aseptic processing, environmental monitoring, equipment design and cleaning, laboratory controls, quality unit responsibilities, and personnel training. The observations highlight significant deficiencies in preventing microbiological contamination, ensuring product purity, and adequately investigating discrepancies and complaints. The firm also failed to conduct timely stability testing and ensure proper visual inspection of drug products.
ID · e578fe89-e979-4212-a934-706675c1e96e